96
Views
37
CrossRef citations to date
0
Altmetric
Research Article

The Quinoxaline Derivative Caroverine in the Treatment of Sensorineural Smell Disorders: a Proof-of-Concept Study

, , &
Pages 877-881 | Published online: 08 Jul 2009

  • Hoffman HJ, Ishii EK, MacTurk RH. Age-related changes in the prevalence of smell/taste problems among the United States adult population Results of the 1994 disability supplement to the National Health Interview Survey (NHIS). Ann N Y Acad Sei 1998; 855: 716-22.
  • Quint C, Temmel AF, Schickinger B, Pabinger S, Ramberger P, Hummel T. Patterns of non-conductive olfactory disorders in eastern Austria: a study of 120 patients from the Department of Otorhinolaryngology at the University of Vienna. Wien Klin Wochenschr 2001 ; 113: 52-7.
  • Duncan HJ, Smith DV. Clinical disorders of olfaction. A review. In: Doty RL, ed. Handbook of olfaction and gustation. New York: Marcel Dekker, 1995: 345.
  • Temmel AFP, Quint C, Schickinger-Fischer B, Klimek L, Stoller E, Hummel T. Characteristics of olfactory disorders in relation to major causes of olfactory loss. Arch Otolaryngol Head Neck Surg 2002; 128; 635-41.
  • Seiden AM. Olfactory loss secondary to nasal and sinus pathology. In: Seiden AM, ed. Taste and smell disorders. New York: Thieme, 1997: 52-71.
  • Ehrenberger K, Felix D. Receptor pharmacological models for inner ear therapies with emphasis on glutamate receptors: a survey. Acta Otolaryngol (Stockh) 1995; 115: 236-40.
  • Schoppa NE, Kinzie JM, Sahara Y, Segerson TP, Westbrook GL. Dendrodendritic inhibition in the olfactory bulb is driven by NMDA receptors. J Neurosci 1998; 18: 6790-802.
  • Ehrenberger K, Felix D. Caroverine depresses the activity of cochlear glutamate receptors in guinea pigs: in vivo model for drug-induced neuroprotectioa Neuropharmacology 1992; 31: 1259-63.
  • Pujol R, Fuel JL. Excitotoxicity, synaptic repair, and functional recovery in the mammalian cochlea: a review of recent findings. Ann N Y Acad Sei 1999; 884:249-54.
  • Henkin RI, Schlechter PJ, Friedewald WT, Demets DL, Raff M. A double blind study of the effects of zinc sulfate on taste and smell dysfunction. Am J Med Sei 1976; 272: 285-99.
  • Seiden AM. The initial assessment of patients with taste and smell disorders. In: Seiden AM, ed. Taste and smell disorders. New York: Thieme, 1997: 4-19.
  • Hummel T, Sekinger B, Wolf SR, Pauli E, Kobal G. "Sniffin' Sticks": olfactory performance assessed by the combined testing of odor identification, odor discrimination, and olfactory thresholds. Chem Senses 1997; 22: 39-52.
  • Kobal G, Hummel T, Sekinger B, Barz S, Roscher S, WoIf SR. "Sniffin' Sticks": screening of olfactory performance. Rhinology 1996; 34: 222-6.
  • Ehrenstein WH, Ehrenstein A. Psychophysical methods. In: Windhorst U, Johansson H, eds. Modern techniques in neuroscience research. Berlin: Springer, 1999: 121141.
  • Kobal G, Klimek L, Wolfensberger M, et al. Multicenter investigation of 1,036 subjects using a standardized method for the assessment of olfactory function combining tests of odor identification, odor discrimination, and olfactory thresholds. Eur Arch Otorhinolaryngol 2000; 257: 205-11.
  • Aroniadou-Anderjaska V, Ennis M, Shipley MT. Dendrodendritic recurrent excitation in mitral cells of the rat olfactory bulb. J Neurophysiol 1999; 82: 489-94.
  • Oestreicher E, Arnold W, Ehrenberger K, Felix D. New approaches for inner ear therapy with glutamate antagonists. Acta Otolaryngol (Stockh) 1999; 119: 174-8.
  • Mangano DT, Mangano CM. Perioperative stroke, encephalopathy, and central nervous system dysfunction. J Int Care Med 1997; 12: 148-60.
  • Bredt DS, Snyder SH. Nitric oxide mediates glutamatelinked enhancement of cgmp levels in the cerebellum. Proc Nat1 Acad Sei USA 1989; 86: 9030-3.
  • Lubec B, Hayn M, Denk W, Bauer G. Brain lipid peroxidation and hydroxy radical attack following the intravenous infusion of hydrogen peroxide in an infant. Free Radie Biol Med 1996; 21: 219-23.
  • Rothman SM, Olney JW. Excitotoxicity and the NMDA receptor - still lethal after eight years. Trends Neurosci 1995; 18: 57-8.
  • Fagg GE, Foster AC. Amino acid neurotransmitters and their pathways in the mammalian central nervous system. Neuroscien? 1983; 9: 701-19.
  • Drian MJ, Kamenka JM, Pirat JL, Privat A. Non-competitive antagonists of N-methyl-D-aspartate prevent spontaneous neuronal death in primary cultures of embryonic rat cortex. J Neurosci Res 1991; 29: 133-8.
  • Mosinger JL, Price MT, Bai HY, Xiao H, Wozniak DF, Olney JW. Blockade of both NMDA and nonNMDA receptors is required for optimal protection against ischemie neuronal degeneration in the in vivo adult mammalian retina. Exp Neurol 1991; 113: 10-7.
  • Tremblay R, Chakravarthy B, Hewitt K, et al. Transient NMDA receptor inactivation provides long-term protection to cultured cortical neurons from a variety of death signals. J Neurosci 2000; 20: 7183-92.
  • Barnett HJM, Eliasziw M, Meldrum HE. Drugs and surgery in the prevention of ischemic stroke. N Engl J Med 1995; 332: 238-48.
  • Cassirer AM. The missing zinc. J Am Med Womens Assoc 1981; 36: 269.
  • Aiba T, Sugiura M, Mori J, et al. Effect of zinc sulfate on sensorineural olfactory disorder. Acta Otolaryngol Suppl (Stockh) 1998; 538: 202-4.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.